ERBB3 & CD221, Human (Istiratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-ERBB3 & CD221, Human (Istiratumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityERBB3 & CD221, Human (Istiratumab biosimilar)
CloneIstiratumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa -[scFv]2
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human ERBB3 & CD221 Recombinant Antibody. Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer.
Immunogenn/a
Other NamesAnti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab, Anti-Human ERBB3 & CD221 Recombinant Antibody, MM-005, MM-141, Antibody Drug Analogues, Monoclonal Antibody, YR1370, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1509928-04-4
Catalog #YR1370
Priceplease inquire
Order / More InfoERBB3 & CD221, Human (Istiratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.